Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Leopoldo Laricchia Robbio"'
Autor:
Josipa Bilic, Julian Pulecio, Marianna Vitaloni, Bernd Kuebler, Juan Carlos Izpisua Belmonte, Leopoldo Laricchia-Robbio
Publikováno v:
Journal of Biological Chemistry. 289:2084-2098
Induced pluripotent stem cells (iPSCs) maintain during the first few culture passages a set of epigenetic marks and metabolites characteristic of their somatic cell of origin, a concept defined as epigenetic donor memory. These residual somatic featu
Autor:
Meritxell Carrió, Cristina Pardo, Cristina Morera, Mercè Martí, Lola Mulero, Juan Carlos Izpisua Belmonte, Leopoldo Laricchia-Robbio, Concepcion Rodriguez Esteban
Publikováno v:
Nature Protocols. 8:223-253
Characterization of pluripotent stem cells is required for the registration of stem cell lines and allows for an impartial and objective comparison of the results obtained when generating multiple lines. It is therefore crucial to establish specific,
Publikováno v:
The International Journal of Developmental Biology. 56:729-735
Induced pluripotent stem cells (iPSCs) have the ability to differentiate towards various cell types of the adult organism and are a potential source of transplantable material in regenerative medicine. The entire process of conversion of iPSCs into t
Autor:
S. Rueb, Pieter F. W. Stouten, Celia Quevedo, Shuning He, Leopoldo Laricchia-Robbio, Ida Paramonov, J. C. Izpisua Belmonte, Richard A.J. Janssen, Sergio Menendez, Suzanne Camus, B. E. Snaar-Jagalska
Publikováno v:
Oncogene; Vol 31
Oncogene
Oncogene
Angiogenesis is essential for development and tumor progression. With the aim of identifying new compound inhibitors of the angiogenesis process, we used an established enhanced green fluorescent protein-transgenic zebrafish line to develop an automa
Autor:
Giuliano Testa, Victoria Angelova, Leopoldo Laricchia-Robbio, Gregorio Chejfec, Enrico Benedetti, Tiffany Anthony, Damiano Rondelli
Publikováno v:
Clinical Transplantation. 24:334-340
Ischemic preconditioning (IP) exerts a protective effect on tissues undergoing prolonged ischemia. No studies have been performed to assess the clinical impact of IP on normal human liver used for living donor transplantation (LDLT). Heterologous pre
Autor:
Giuseppina Nucifora, Donglan Li, Leopoldo Laricchia-Robbio, Ciro R. Rinaldi, Soumen Chakraborty, Raffaella Fazzina, Kisaly K. Sinha
Publikováno v:
Molecular and Cellular Biology. 26:7658-7666
EVI1 is an aggressive nuclear oncoprotein deregulated by recurring chromosomal abnormalities in myelodysplastic syndrome (MDS). The expression of the corresponding gene is a very poor prognostic marker for MDS patients and is associated with severe d
Publikováno v:
Gene. 368:1-11
The ecotropic viral integration site 1 (EVI1) gene was identified almost 20 years ago as the integration site of an ecotropic retrovirus leading to murine myeloid leukemia. Since its identification, EVI1 has slowly been recognized as one of the most
Publikováno v:
Biosensors and Bioelectronics. 19:1753-1758
In this study, an automated surface plasmon resonance (SPR)-based biosensor was compared with a quartz crystal microbalance (QCM) biosensor. The two biosensor systems were used for characterizing a site-directed monoclonal antibody (mAb), raised agai
Autor:
Guillermo Guenechea, Ilir Dubova, Marianna Vitaloni, Emmanuel Nivet, Julian Pulecio, Leopoldo Laricchia-Robbio, Juan Carlos Izpisua Belmonte, Yun Xia, Juan A. Bueren, Leo Kurian, Ignacio Sancho-Martinez
Publikováno v:
Stem cells (Dayton, Ohio)
Stem cells (Dayton, Ohio), 2014, 32 (11), pp.2923--2938. ⟨10.1002/stem.1800⟩
Stem cells (Dayton, Ohio), 2014, 32 (11), pp.2923--2938. ⟨10.1002/stem.1800⟩
Reprogramming technologies have emerged as a promising approach for future regenerative medicine. Here, we report on the establishment of a novel methodology allowing for the conversion of human fibroblasts into hematopoietic progenitor-like cells wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82125738354c677e71e677ed2ae9e2e1
https://hal.archives-ouvertes.fr/hal-01736193
https://hal.archives-ouvertes.fr/hal-01736193
Autor:
Alessandra Guidi, Giancarlo Del Bono, Leopoldo Laricchia-Robbio, Roberto P. Revoltella, Daniela Gianfaldoni
Publikováno v:
Università di Pisa-IRIS
Recombinant bovine somatotropin (rBST) treatment is adopted in dairy cows to augment milk yield. Previous studies showed that insulin-like growth factor-1 (IGF-1) is present in milk from cows treated with rBST. Since IGF-1 is a suspected carcinogen,